| 1 |
Dr. Sunil Martin |
Scientist E-II, Cancer Research |
Synthetic Immunology of Engineered Immune Effector Cells to Target Refractory Malignancies |
1 |
| 2 |
Dr. Anish Kundu |
Scientist C, Plant Biotechnology & Disease Biology |
Decoding Calcium–Purine Crosstalk in Endophyte-Mediated Plant Growth |
1 |
| 3 |
Dr. Priya Srinivas |
Scientist G, Cancer Research |
Development of Noninvasive Diagnostics for Ovarian Cancer |
1 |
| 4 |
Dr. Shijulal Nelson Sathi |
Scientist E-I, Transdisciplinary Biology |
AI-Guided De Novo Design of Antibacterial Peptides Targeting ESKAPE Pathogen Membranes |
1 |
| 5 |
Dr. Karthik Subramanian |
Scientist E-I, Pathogen Biology |
Identification of Extracellular Vesicle-Associated Molecular Signatures in Bacterial Pneumonia |
1 |
| 6 |
Dr. Rajesh Chandramohanadas |
Scientist F,Pathogen Biology |
Mapping the Genomic Landscape of Divergent Malaria Parasites in View of Evolving Drug Resistance |
1 |
| 7 |
Dr. Mahendran K R |
Scientist E-II, Transdisciplinary Biology |
Functional Engineering of Bacterial Porins for Antibiotic Transport |
1 |
| 8 |
Dr. Tessy Thomas Maliekal |
Scientist F, Cancer Research |
Investigating the Role of EPHA2 in Oral Cancer Progression and Recurrence |
1 |
| 9 |
Dr. Debasree Dutta |
Scientist F, Regenerative Biology |
Signaling and Chromatin in Dictating States of Pluripotency in Embryonic Stem Cells from Different Mammalian Species |
2 |
| Chromatin Contribution to Drug Resistance |
| 10 |
Dr. S. Asha Nair |
Scientist G, Cancer Research |
Colorectal Cancer Organoids for Predicting Drug Resistance and Therapeutic Plausibility: A Prospective Study |
1 |
| 11 |
Dr. Kathiresan Natarajan |
Scientist E-I, Transdisciplinary Biology |
Molecular and Functional Characterization of the TUBA1A Tubulin Isotype: Implications for Microtubule Dynamics and Tubulinopathies |
1 |
| 12 |
Dr. Leny Jose |
Scientist E-I, Pathogen Biology |
Targeting HPV Pathogenesis Using Bifunctional Protein Degraders |
1 |
| 13 |
Dr. Devasena Anantharaman |
Scientist F,Cancer Research |
Characterization of Mucus in Oral Cancer and Development and Characterization of Oral Cancer Progression Models |
1 |
| 14 |
Dr. Rashmi Mishra |
Scientist E-II, Neurobiology |
Decoding the Brain Glyco-Code: From Neurodevelopment and Cognitive Function to the Pathogenesis of Aggressive Brain Cancers |
2 |
| Deciphering Membrane Activation and Mechanotransduction in the Glioblastoma Microenvironment: Mechanistic Insights and Therapeutic Opportunities |